DLG2 was downregulated in IBD (log2 FC = 0.81, p < 0.05), adenoma (log2 FC = 1.1, p < 0.1) and colon cancer (log2 FC = 1.3, p < 0.01; Fig. 1a). Here, DLG2 is linked to inflammatory bowel disease.